Search Results
Found 18 results for "spain" across articles, medicines, trials, companies and the glossary
MedicinesAll 14 →
Atorvastatin OPKO 40 mg film coated tabletsAtorvastatin calcium trihydrate · Opko Health Spain S.L.U.
Esomeprazole Tillomed 40 mg powder for solution for injection/infusionEsomeprazole · Laboratorios Tillomed Spain, S.L.U.
mCOMBRIAX dispersion for injection in pre-filled syringe. Influenza and COVID-19, mRNA vaccine.mRNA encoding Influenza A, H1N1 strain, hemagglutinin glycoprotein, mRNA encoding Influenza A, H3N2 strain, hemagglutinin glycoprotein, mRNA encoding Influenza B/Victoria, hemagglutinin glycoprotein, mRNA-1283 · Moderna Biotech Spain S.L.
mNEXSPIKE dispersion for injection in pre-filled syringe COVID-19 mRNA VaccinemRNA-1283 · Moderna Biotech Spain S.L.
mRESVIASingle-stranded 5' capped mRNA encoding the Respiratory syncytial virus glycoprotein F stabilized in the prefusion conformation · Moderna Biotech Spain S.L.
RimmyrahRanibizumab · Qilu Pharma Spain S.L.
MedTech
Ubotica Secures $11 Million to Roll Out Satellite-Based Orbital AI Maritime Intelligence Platform
Space-tech leader Ubotica has closed an $11 million funding round led by Act Venture Capital and Greencode Ventures to scale its real-time Live Maritime Intelligence platform powered by direct satellite AI processing.
Regulatory Affairs
UK Looks to Spain’s "Catalonia Blueprint" to Boost Global Clinical Trials Competitiveness
As global competition intensifies, UK life sciences leaders are examining Spain’s thriving Catalonia region for strategies to attract commercial sponsors, streamline regulatory reviews, and revitalize Britain’s clinical trials sector.
Pharmaceutical
The Cascade Effect: How US MFN and IRA Pricing Mandates Are Reshaping Drug Development, Launch Sequencing, and Ireland’s Life Sciences Sector
An in-depth analysis of how US Most Favored Nation (MFN) drug pricing proposals and the Inflation Reduction Act (IRA) are forcing pharmaceutical companies to restructure indication sequencing, ex-US launches, and global supply chains.
Regulatory Affairs
How Most Favored Nation (MFN) Pricing Impacts Drug Development & Launch Planning
An expert analysis of the strategic shifts required in global drug development, indication sequencing, and launch timelines in response to proposed Most Favored Nation pricing and the Inflation Reduction Act.